Omega Therapeutics (OMGA) IPO Opens 30% Higher

July 30, 2021 11:57 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Today's IPO for Omega Therapeutics, Inc. (Nasdaq: OMGA) opened for trading at $22.10 after pricing 7,400,000 shares of its common stock at a price to the public of $17.00 per share, the middle of the expected $16-$18 range.

Goldman Sachs & Co. LLC, Jefferies LLC and Piper Sandler are acting as joint book-running managers of the offering. Wedbush PacGrow is acting as lead manager.

Omega Therapeutics is a development-stage biotechnology company leveraging its OMEGA Epigenomic Programming platform to harness the power of epigenetics to develop a new class of DNA-sequence-targeting, mRNA-encoded programmable epigenetic medicines.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Goldman Sachs, Jefferies & Co, IPO